Not that anyone reads these posts - but might one day - MSB just saw an intra-day mkt cap jump of some $60 million simply on an FDA designation of one of its applications as a Rare Pediatric Disease (RPD) Designation. Such 'vouchers' are tradeable and have fetched somewhere between $20-$350 million in the past:
https://www.prnewswire.com/news-releases/united-therapeutics-corporation-agrees-to-sell-priority-review-voucher-to-abbvie-for-350-million-300130415.html#:~:text=Upon%20closing%20of%20the%20transaction,treatment%20of%20rare%20pediatric%20diseases.
IP is very difficult to value, but when companies literally trade designations with each other it gives more tangible insight to the potential valuation involved.
- Forums
- ASX - By Stock
- CMB
- Ann: Chairman's Address and CEO update
Ann: Chairman's Address and CEO update, page-10
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $3.064M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $82 | 20.53K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1596661 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 746300 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1596661 | 0.004 |
4 | 1868663 | 0.003 |
3 | 2200000 | 0.002 |
3 | 2800990 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 746300 | 6 |
0.007 | 185729 | 2 |
0.008 | 448500 | 1 |
0.014 | 20000 | 1 |
0.015 | 500000 | 1 |
Last trade - 12.16pm 01/07/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online